Key facts
- Solas Capital Management, LLC filed SCHEDULE 13G for MAIA Biotechnology, Inc. Common Stock, $0.0001 par value per share (MAIA).
- Disclosed ownership: 7.1%.
- Date of event: 31 Mar 2026.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Solas Capital Management, LLC | 7.1% | 4,297,004 | 0 | 4,297,004 | /s/ Frederick Tucker Golden | General Partner, Solas Capital Holdings, LP, its Member | |
| FREDERICK TUCKER GOLDEN | 7.1% | 4,297,004 | 0 | 4,297,004 | /s/ Frederick Tucker Golden | Frederick Tucker Golden |
CIK / CUSIP context first